Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Tirzepatide (Zepbound) and semaglutide (Rybelsus) are both medications used to help manage weight and treat conditions related to obesity, and they work in a similar way. Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, while semaglutide is solely a GLP-1 receptor agonist. Both medications can help with weight loss, but only tirzepatide is FDA-approved for weight management and sleep apnea, whereas semaglutide is approved for Type 2 diabetes. Tirzepatide is administered as a weekly injection, while semaglutide is taken orally once a day. Common side effects for both include nausea and diarrhea, but tirzepatide may also cause injection site reactions. Both medications can lead to low blood sugar if combined with certain diabetes medications. Neither medication is available in a generic form. Additionally, both tirzepatide and semaglutide carry a risk of thyroid cancer, and you should avoid them if you have a personal or family history of thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN 2).
Zepbound (tirzepatide)
Rybelsus (semaglutide)
Zepbound (tirzepatide)
Rybelsus (semaglutide)
Summary of Zepbound vs. Rybelsus
Summary for GIP and GLP-1 agonist
Prescription only
Zepbound (tirzepatide) is an injectable medication that's used along with diet and exercise. It helps with weight loss in adults who meet criteria for weight management therapy. It's also approved to treat moderate-to-severe sleep apnea. This medication belongs to the drug class called GIP and GLP-1 agonists. The dosage is 1 injection under the skin once a week. Common side effects include nausea, diarrhea, and injection site reactions. Zepbound (tirzepatide) is only available as a brand-name medication.
Summary for GLP-1 agonist
Prescription only
Rybelsus (semaglutide) is a brand-name GLP-1 agonist that helps lower blood sugar in adults with Type 2 diabetes. It's also FDA approved to help reduce the risk of heart attack, stroke, and heart-related death in people with Type 2 diabetes who are at risk for these events. The medication comes as a pill that's taken by mouth once a day, at least 30 minutes before you eat, drink, or take any other medications by mouth. It’s used along with diet and exercise, and might also help with weight loss. Common side effects include nausea, stomach pain, and diarrhea.